US Patent Issued to Roche Diabetes Care on March 31 for "Continuous analyte sensor with magnetic activation" (German Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,588,837, issued on March 31, was assigned to Roche Diabetes Care Inc. (Indianapolis).

"Continuous analyte sensor with magnetic activation" was invented by Frederic Wehowski (Hockenheim, Germany) and Hans List (Oberzent, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "An analyte measurement kit includes a sensor assembly having a transcutaneous sensor and a controller. The controller includes a battery that powers the sensor assembly and includes a magnetic sensor that generates an electrical activation signal in dependence of a magnetic field. The controller switches from a pre-operative state into an operative state upon generation of the activ...